ABOUT US
20/20 Onsite is a healthcare services company providing clinical trial solutions that transform the delivery of vision care by radically improving patient access through state-of-the-art Mobile Vision Clinics. 20/20 Onsite's integrated point-of-need service delivery platform has taken high-value eye assessment services directly to patients at work, at school, in neighborhoods, and at clinical research sites. During the pandemic, 20/20 Onsite began bringing ophthalmic assessments to patients in clinical trials or post-marketing safety surveillance programs nationwide, increasing access to clinical research. 20/20 Onsite enables and accelerates fundamental trends toward the consumerization of care and the decentralization of clinical trials.
20/20 Onsite has served over 85,000 patients, including 22 clinical trials, met 100% of screening timelines across operations, and consistently reports patient NPS scores of over 94.
FEATURED ARTICLES
-
![medical worker write documents, data and questions for report, planning or clinic administration-GettyImages-1511333905]( "The Clinical Trial Rescue Triage Playbook")
Quickly assess clinical trial risks by evaluating site impact, patient safety, and budget tradeoffs. Turn high-pressure rescue scenarios into clear, actionable paths for your research team.
-
![GettyImages-820772090 eyes]( "At-Home Clinical Trials: When At-Home Ophthalmic Exams Make Sense")
At-home ophthalmic exams in clinical trials improve patient accessibility, reduce site burden, and maintain data integrity, enabling decentralized research without sacrificing quality or compliance.
-
![GettyImages-1938542776 doctor patient]( "Why Clinical Trial Demographics Don't Match Real-World Populations")
Representative trial demographics reduce bias, strengthen safety insights, and ensure therapies work for all. Learn why diversity is essential for accurate data and better health outcomes.
-
![GettyImages-1054148730-clinical-outsourcing-partner-FSP]( "How Mobile Clinics Advance Diversity In Clinical Research")
Mobile clinics reduce participation barriers, enable more inclusive trials, deliver representative data, speed timelines, and advance equity in research.
-
![GettyImages-1314079629 virtual meeting]( "Virtual Clinical Trials For Ophthalmic Measures")
Remote ophthalmic assessments such as BCVA, OCT, and IOP expand trial access and efficiency, preserving data quality while reducing site burden and boosting patient engagement.
-
![iStock-862563678-ophthalmic-optometry-eye-exam]( "The Site Playbook: Start Smart, Finish Fast")
Clinical research sites often face ophthalmic endpoint challenges, causing delays, deviations, dropouts, and burnout. Check out the four-step framework to overcome these issues efficiently.
-
![Eye]( "The Clinical Imaging Strategy That Safeguards Your Trial's Ocular Endpoints")
GLP1 and neurology trials depend on detecting subtle retinal or neuro-ophthalmic changes early. By planning an imaging strategy upfront, sponsors can de-risk studies and protect critical endpoints.
-
![20 20 onsite]( "5 Proven Ways To Expand Clinical Trial Site Capacity")
How can you turn capacity limits into enrollment momentum and ensure timelines stay on track while also expanding access to diverse patient populations?
-
![iStock-1193272050-eye]( "GLP‑1 Clinical Trial Eye Safety: Semaglutide Eye Risks")
While GLP-1 receptor agonists offer significant health benefits, proactive eye care and vigilance are essential to mitigate the risk of irreversible ocular conditions.
-
![2020 Onsite What We Do Josh Anderson]( "What Sponsors Must Know To Safeguard Ocular Endpoints")
Explore the necessity of incorporating imaging methodologies early in the trial design to improve data quality and overall trial efficiency.
CONTACT INFORMATION
20/20 Onsite
29 Garden Street
Everett, MA 02149
UNITED STATES
Phone: 617-812-9453
Contact: Jessica McKenzie, Vice President, Life Sciences